seasonal trivalent inactivated influenza vaccine

BIOLOGICAL2 trials

Sponsors

PATH

Conditions

Influenza

Phase 2

Immunogenicity and Safety Trial of Adjuvanted and Non-adjuvanted Trivalent Influenza Vaccine in Tropical Africa

CompletedNCT01819155

Start: 2013-04-30End: 2013-09-30Updated: 2013-10-22

Phase 4

Inactivated Influenza Vaccine Effectiveness in Tropical Africa

CompletedNCT00893906

Start: 2009-05-31End: 2013-04-30Target: 10000Updated: 2013-09-23

Related Papers

Estimates of Inactivated Influenza Vaccine Effectiveness Among Children in Senegal: Results From 2 Consecutive Cluster-Randomized Controlled Trials in 2010 and 2011

Clinical Infectious Diseases2020-10-309 citations

Immunogenicity of seasonal inactivated influenza and inactivated polio vaccines among children in Senegal: Results from a cluster-randomized trial.

2020-10-021 citations

Effectiveness of Seasonal Influenza Vaccination in Children in Senegal During a Year of Vaccine Mismatch: A Cluster-randomized Trial

Clinical Infectious Diseases2019-01-1825 citations

Immunogenicity and safety of MF59-adjuvanted and full-dose unadjuvanted trivalent inactivated influenza vaccines among vaccine-naïve children in a randomized clinical trial in rural Senegal.

2018-09-1412 citations

Efficacy of a Russian-backbone live attenuated influenza vaccine among children in Senegal: a randomised, double-blind, placebo-controlled trial.

2016-10-1349 citations